Krsnaa Diagnostics Ltd

KRSNAA

Watchlist

AI Mode

‌

Market Cap

₹ 2,428 Cr

P/E

28.71

‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Krsnaa Diagnostics Limited is one of India's largest integrated diagnostic service providers, specializing in radiology and pathology with a vast network across non-metro and tier-two cities and towns.

Krsnaa achieved an all-time high quarterly PAT of INR 239 million, marking a 22% year-on-year growth. The company's margins strengthened significantly due to strategic operational leverage.

The company uniquely operates under a Public Private Partnership model, allowing it to offer quality diagnostic services at significantly reduced costs, exemplified by pricing nearly 70% lower than competitors.

Strategic expansion is evident with forthcoming operational launches of AI-enabled MRI centers and low radiation CT centers, enhancing Krsnaa's infrastructure and diagnostic capabilities.

Krsnaa's retail segment saw a remarkable quarterly revenue increase of 60%, with broader participation in the retail diagnostic market projected to offer significant future revenue contributions.

Sector

Healthcare

Industry

Diagnostic Services

Market Cap

2,428 Cr

Volatility

High Risk

P/E Ratio

28.7

Industry P/E

48.3

PEG Ratio

0.9

P/B Ratio

2.6

52W High

969.85

52W Low

628.00

Sales CAGR

15.76%

14.44%

21.41%

10Y

—

Profit CAGR

36.54%

5.41%

—

10Y

—

ROE

TTM

9.16%

8.36%

13.67%

10Y

—

ROCE

TTM

11.09%

11.60%

19.16%

10Y

—

Technicals

‌

Forecasts

No. of Analysts

7

1Y Price Target

1182.52 ▲ 60.67%

Q3 EPS Estimate

Q3 Revenue Estimate

Unlock Premium Features

Price, EPS and Revenue Projections

Strong SellSellHoldBuyStrong Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

updated on

Nov 14, 2025

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIMTALABS	611.90	2,719 Cr	44.73	7.93	0.16	14.59	19.04	13.94
KRSNAA	742.75	2,428 Cr	28.71	2.63	0.37	9.16	11.09	5.61
SURAKSHA	285.60	1,485 Cr	46.53	6.45	0.00	13.86	14.74	8.19
ONEGLOBAL	606.65	1,186 Cr	27.02	11.70	0.00	43.51	58.07	19.53
CHANDAN	293.90	719 Cr	32.40	5.86	0.00	19.63	21.52	10.52
QLL	400.00	466 Cr	74.07	3.36	0.00	0.00	0.00	2.06
STARIMAGIN	104.15	182 Cr	11.45	1.77	0.00	18.49	23.03	13.19

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	140	155	158	166	170	186	175	186	193	206
Expenses	108	124	121	123	128	137	129	133	142	147
Operating Profit	31	32	37	44	43	49	45	53	51	59
OPM %	22.47	20.44	23.62	26.28	25.07	26.51	25.83	28.48	26.63	28.72
Other Income	4.22	4.16	4.08	4.34	7.32	4.59	9.24	4.39	3.96	4.18
Interest	1.96	3.06	4.15	7.32	5.32	6.39	6.13	6.81	6.30	8.19
Depreciation	16	19	21	18	21	22	23	22	22	24
Profit Before Tax	18	13	16	23	23	25	25	29	27	32
Tax %	18.17	21.76	19.38	17.16	22.76	22.87	23.78	27.72	25.16	24.14
Net Profit	15	11	13	19	18	20	19	21	21	24
EPS in Rs	4.37	3.13	3.95	5.67	5.43	5.89	5.85	6.25	6.25	7.25

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	455	487	620	717	740
Expenses	324	365	475	527	541
Operating Profit	131	122	144	190	199
OPM %	28.87	25.11	23.28	26.51	26.88
Other Income	15	19	17	26	22
Interest	18	7.70	16	25	26
Depreciation	41	54	75	88	88
Profit Before Tax	87	80	70	103	107
Tax %	20.95	22.56	18.81	24.42	24.96
Net Profit	68	62	57	78	80
EPS in Rs	22.95	19.55	17.13	23.43	25.60
Dividend Payout %	10.93	14.26	14.44	11.67	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	16	16
Reserves	669	723	794	867
Borrowings	41	32	160	204
Other Liabilities	151	139	202	195
Total Liabilities	876	910	1,172	1,282
Fixed Assets	386	471	647	670
CWIP	28	25	9.85	2.96
Investments	0.29	0.29	0.29	32
Other Assets	462	413	515	577
Total Assets	876	910	1,172	1,282

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	128	76	24	87
Cash from Investing Activity	-241	-109	-129	-100
Cash from Financing Activity	176	-33	84	14
Net Cash Flow	64	-66	-20	1.47

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	27.80%	27.80%	27.80%	27.80%	27.03%	27.03%	27.17%	27.17%	27.24%	27.24%	27.11%	27.11%
FIIs	4.14%	3.38%	5.70%	3.68%	3.44%	3.34%	3.33%	3.63%	4.04%	3.55%	3.40%	3.67%
DIIs	19.40%	18.49%	19.76%	18.73%	16.58%	15.37%	15.26%	15.86%	14.46%	14.26%	14.24%	14.96%
Public	48.66%	50.33%	46.74%	49.79%	52.95%	54.26%	54.24%	53.34%	54.27%	54.94%	55.25%	54.26%
Total Shareholders	68,688	67,116	62,257	60,665	57,232	56,458	55,914	53,519	52,799	53,559	54,262	52,117

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Dec 31, 2024	Krsna diagnostics mumbai pri...	Insider - Promoter Group	Acquisition	870.89	2.00 Cr	22,929	0.07
Jun 12, 2024	Kitara piin 1104	Bulk	Sell	600.69	22.35 Cr	3,72,000	1.15
Jun 06, 2024	Krsna diagnostics mumbai pri...	Insider - Promoter Group	Acquisition	540.86	2.43 Cr	45,000	0.13
Sep 28, 2023	Invesco mutual fund	Bulk	Sell	675.02	13.18 Cr	1,95,305	0.60
Sep 28, 2023	Miv investment services priva...	Bulk	Buy	675.00	10.79 Cr	1,59,909	0.49
May 09, 2023	Acm global fund vcc	Bulk	Buy	495.25	34.21 Cr	6,90,857	2.13
May 09, 2023	Somerset indus healthcare fun...	Bulk	Sell	495.27	44.12 Cr	8,90,857	2.75

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Board Meeting Outcome

4 days ago

Board Meeting Approves NCD Issuance

Krsnaa Diagnostics' Board has approved the issuance of unlisted secured redeemable and transferable non-convertible debentures worth up to INR 430 crores on December 12, 2025.

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q1 FY25

Investor Presentation

Q1 FY25

Showing 1 - 8 of 20

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
VIMTALABS	611.90	2,719 Cr	44.73	7.93	0.16	14.59	19.04	13.94
KRSNAA	742.75	2,428 Cr	28.71	2.63	0.37	9.16	11.09	5.61
SURAKSHA	285.60	1,485 Cr	46.53	6.45	0.00	13.86	14.74	8.19
ONEGLOBAL	606.65	1,186 Cr	27.02	11.70	0.00	43.51	58.07	19.53
CHANDAN	293.90	719 Cr	32.40	5.86	0.00	19.63	21.52	10.52
QLL	400.00	466 Cr	74.07	3.36	0.00	0.00	0.00	2.06
STARIMAGIN	104.15	182 Cr	11.45	1.77	0.00	18.49	23.03	13.19

Oscillators

BearishNeutralBullish

Bullish

Bearish

Diagnostic Services

Market Cap

2,428 Cr

Volatility

High Risk

P/E Ratio

28.7

Industry P/E

48.3

PEG Ratio

0.9

P/B Ratio

2.6

52W High

969.85

52W Low

628.00

Sales CAGR

15.76%

14.44%

21.41%

10Y

—

Profit CAGR

36.54%

5.41%

—

10Y

—

ROE

TTM

9.16%

8.36%

13.67%

10Y

—

ROCE

TTM

11.09%

11.60%

19.16%

10Y

—